MARK4 and breast cancer: To test our hypothesis that MARK4 down‐regulation was the mechanism through which miR‐515‐5p affected breast cancer cell migration, we tested whether overexpressing MARK4 in miR‐515‐5p‐transfected cells could rescue the reduced cell motility.